CH97978A - Process for the preparation of diallyl xanthine. - Google Patents
Process for the preparation of diallyl xanthine.Info
- Publication number
- CH97978A CH97978A CH97978DA CH97978A CH 97978 A CH97978 A CH 97978A CH 97978D A CH97978D A CH 97978DA CH 97978 A CH97978 A CH 97978A
- Authority
- CH
- Switzerland
- Prior art keywords
- diallyl
- preparation
- xanthine
- diamino
- alcohol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Darstellung von Diallylganthin. Es wurde gefunden, dass man zu dem bis her unbekannten Diallylxanthin gelangen kann, indem man die Formylverbindung des 1 . 3-Diallyl-4 . 5-diamino-2 . 6-dioxypyrimi- dins mit Alkalien, beispielsweise mit Natron lauge, behandelt.
Die als Ausgaugsstoff dienende Formyl- verbindung des 1.3-Diallyl-4.5-diamino- 2.6-dioxypyriinidins kann in folgender Weise erhalten werden: Man kondensiert Diallylh.arnstoff mit Cyanessigsäure oder Cyanessigester und führt,das Kondensations produkt mit salpetriger Säure in Diallyl-iso- nitrosoaininodioxypyrimidin über.
Letzteres wird zu Diallyl-diamino-dioxypyrimidin re duziert und dieses durch Erhitzen mit Amei sensäure forinyliert. Statt mit Cyanessigsäure k -ann man den Diallylharnstoff auch mit Iso- nitroso:cyanessigester kondensieren, in wel chem Falle man direkt zum Isonitrosokörper gelangt.
Die neue Verbindung soll zu therapeu tischen Zwecken verwendet werden. <I>Beispiel:</I> 1 Mol. Formyl-1.3=diallyl-4.5-clia.mino- 2 . 6 . ,clioxy-pyrimidin wird mit 1 Mol. n-Na- tronlauge während 1/4 Stunde auf dem Was serbad erhitzt. Hierauf säuert man in der Wärme mit Essigsäure an und lässt erkalten, worauf das 1 . 3 . Diallylxanthin auskristalli siert. Dasselbe bildet bei 155 bis 156 schmel zende, in kaltem Wasser und kaltem Alkohol sehr schwer, in warmem Wasser und war mem Alkohol, ferner in Äther und Benzol lösliche Kristalle.
PATENTANSPRUCH: Verfahren zur Darstellung von Diallyl- xanthin, dadurch gekennzeichnet, dass man die Formylverbindung des 1 .3-Diallyl-4. 5- diamino-2.6-dioxypyrimidins mit Alkalien behandelt.
Das Triallylxanthin bildet bei 155 bis <B>156'</B> schmelzende, in kaltem Wasser und kaltem Alkohol sehr schwer, in warmem Wasser und warmem Alkohol, ferner in Äther und Benzol lösliche Kristalle.
Process for the preparation of diallylganthin. It has been found that the hitherto unknown diallylxanthine can be obtained by using the formyl compound of 1. 3-diallyl-4. 5-diamino-2. 6-dioxypyrimidines with alkalis, for example with caustic soda, treated.
The formyl compound of 1,3-diallyl-4,5-diamino-2,6-dioxypyriinidine which serves as the exhaust substance can be obtained in the following manner: Diallyl urea is condensed with cyanoacetic acid or cyanoacetate and the condensation product with nitrous acid is converted into diallyl isonitrosoaininodioxypyrimidine above.
The latter is reduced to diallyl-diamino-dioxypyrimidine and this is forinylated by heating with formic acid. Instead of using cyanoacetic acid, the diallylurea can also be condensed with isonitroso: cyanoacetic ester, in which case the isonitroso body is obtained directly.
The new compound is intended to be used for therapeutic purposes. <I> Example: </I> 1 mol. Formyl-1.3 = diallyl-4.5-clia.mino- 2. 6th , Clioxy-pyrimidine is heated with 1 mol. N-sodium hydroxide solution for 1/4 hour on the water bath. Then acidify with acetic acid in the warmth and let it cool, whereupon the 1st 3. Diallylxanthine crystallized out. At 155 to 156 it forms melting crystals, which are very difficult in cold water and cold alcohol, in warm water and were in alcohol, and also crystals soluble in ether and benzene.
PATENT CLAIM: Process for the preparation of diallyl xanthine, characterized in that the formyl compound of 1 .3-diallyl-4. 5- diamino-2,6-dioxypyrimidines treated with alkalis.
The triallyl xanthine forms at 155 to <B> 156 '</B> melting crystals, which are very difficult to dissolve in cold water and cold alcohol, and crystals which are soluble in warm water and warm alcohol, and also in ether and benzene.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH97978T | 1921-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH97978A true CH97978A (en) | 1923-02-16 |
Family
ID=4355743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH97978D CH97978A (en) | 1921-10-07 | 1921-10-07 | Process for the preparation of diallyl xanthine. |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH97978A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2420346A1 (en) * | 1977-04-02 | 1979-10-19 | Hoechst Ag | MEDICINAL PRODUCTS CONTAINING ALCENYLXANTHINS AND THEIR PREPARATION PROCESS |
-
1921
- 1921-10-07 CH CH97978D patent/CH97978A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2420346A1 (en) * | 1977-04-02 | 1979-10-19 | Hoechst Ag | MEDICINAL PRODUCTS CONTAINING ALCENYLXANTHINS AND THEIR PREPARATION PROCESS |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH97978A (en) | Process for the preparation of diallyl xanthine. | |
AT130636B (en) | Process for the production of condensation products from urea or its derivatives and formaldehyde. | |
DE499523C (en) | Process for the production of ª ‡ -oxy acids from their nitriles | |
CH97979A (en) | Process for the preparation of triallyl xanthine. | |
DE954421C (en) | Process for the production of ªŠ-acetyl-lysine | |
DE319368C (en) | Process for the preparation of paraldehyde | |
AT78986B (en) | Process for the preparation of water-soluble condensation products. | |
DE539806C (en) | Process for the preparation of isopropylallylbarbituric acid | |
DE945926C (en) | Process for the production of ªŠ-acetyl-lysine | |
DE421217C (en) | Method for the preparation of codeinone | |
DE511644C (en) | Process for the preparation of porphyrins | |
DE856435C (en) | Process for the preparation of cyclohexenylsuccinic acid | |
DE347375C (en) | Process for the preparation of nitro-3-quinolines | |
CH111996A (en) | Method for the preparation of codeinone. | |
AT129790B (en) | Process for the preparation of condensation products from cyanamide and formaldehyde. | |
DE293693C (en) | ||
CH131273A (en) | Process for the production of condensation products of urea. | |
CH100320A (en) | Process for the production of solid formaldehyde solutions. | |
CH125134A (en) | Process for the preparation of 2-styryl-4-amino-6-ethoxy-quinoline. | |
CH149011A (en) | Process for the preparation of an N-substituted compound of the pyridone series. | |
CH125406A (en) | Process for the preparation of a substituted quinoline carboxylic acid derivative. | |
CH243969A (en) | Process for the preparation of a new p-amino-benzenesulfonamide. | |
CH205894A (en) | Process for producing a pyrimidine compound. | |
CH223030A (en) | Process for the production of a condensation product. | |
CH125403A (en) | Process for the preparation of a substituted quinoline carboxylic acid derivative. |